title: Successful Treatment of Non-Small Cell Lung Cancer With Erlotinib Throughout Pregnancy.
authors.affiliation: University of Vermont Cancer Center, Burlington.
authors.forename: Yongli
authors.initials: Y
authors.lastname: Ji
authors.affiliation: Department of Pharmacy Practice, Albany College of Pharmacy, Albany, New York.
authors.forename: Joanna
authors.initials: J
authors.lastname: Schwartz
authors.affiliation: Section of Radiation Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
authors.forename: Alan
authors.initials: A
authors.lastname: Hartford
authors.affiliation: University of Vermont Cancer Center, Burlington.
authors.forename: Jon
authors.initials: J
authors.lastname: Ramsey
authors.affiliation: Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics, University of Vermont Medical Center, Burlington.
authors.forename: Julie
authors.initials: J
authors.lastname: Phillips
authors.affiliation: University of Vermont Cancer Center, Burlington.
authors.forename: Claire
authors.initials: C
authors.lastname: Verschraegen
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000556:secondary; D000077192:Adenocarcinoma of Lung; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000556:secondary; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D000069347:Erlotinib Hydrochloride / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D050498:Live Birth; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D058990:Molecular Targeted Therapy; D009154:Mutation; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D059285:Pregnancy, Twin; D047428:Protein Kinase Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D047428:Protein Kinase Inhibitors; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors